[Form 4] Ryerson Holding Corp Insider Trading Activity

Rhea-AI Filing Summary

Karen Marie Leggio, a director of Ryerson Holding Corp (RYI), received 382 shares of common stock as director compensation on 09/30/2025. The award vested in full on the grant date and was issued at no cash cost ($0 reported). After the grant, Ms. Leggio beneficially owned 4,536 shares. The Form 4 was filed by an attorney-in-fact and signed on 10/02/2025. The filing discloses no derivative transactions and states the award was made under Ryerson's Director Compensation Program.

Positive

• 382 shares awarded as director compensation vested in full on grant date
• Post-transaction beneficial ownership of 4,536 shares disclosed

Negative

• None.

Insights

Corporate Governance Expert

Director received equity compensation: 382 shares vested on grant date.

This Form 4 shows a routine director compensation award under the company's Director Compensation Program. The grant vested immediately and added to the director's existing holdings, bringing total beneficial ownership to 4,536 shares.

Immediate vesting and a $0 reported price indicate the award is a standard equity grant rather than a purchase, and the disclosure was filed by an attorney-in-fact on 10/02/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Leggio Karen Marie

(Last) (First) (Middle)

C/O RYERSON HOLDING CORP.

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (par value $0.01 per share)	09/30/2025		A		382(1)	A	$0	4,536	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date.

	/s/ Camilla Rykke Merrick, attorney-in-fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ryerson Holding Corp (RYI) report on this Form 4?

The Form 4 reports that director Karen Marie Leggio received 382 shares of common stock as compensation on 09/30/2025, vesting in full on the grant date.

How many shares does the reporting director own after the transaction?

After the reported award, the director beneficially owned 4,536 shares of Ryerson common stock.

Was any cash paid for the shares reported on the Form 4?

No; the Form 4 lists a price of $0, indicating the shares were granted as compensation.

When was the Form 4 signed and filed?

The Form 4 was signed by an attorney-in-fact on 10/02/2025 and reports a transaction date of 09/30/2025.

Was the award part of a named program?

Yes; the filing states the award was granted pursuant to Ryerson's Director Compensation Program and vested in full on grant date.